Related Experiment Video
Updated: Jun 8, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Antifungal treatment of small animal veterinary patients
Daniel S Foy1, Lauren A Trepanier
1Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 2015 Linden Drive, Madison, WI 53706, USA. dfoy@svm.vetmed.wisc.edu
Abstract:
Antifungal therapy has progressed significantly with the development of new drugs directed at various processes in fungal cell metabolism. Within veterinary medicine, treatment options for systemic mycoses remain limited to amphotericin B, ketoconazole, fluconazole, and itraconazole. However, newer triazoles, echinocandins, and lipid-based formulations of amphotericin B are now approved for use in humans. This article provides a comprehensive review of the antifungal medications available for veterinary patients, and includes a brief discussion of the newer, presently cost-prohibitive, antifungal therapies used for systemic mycoses in humans.
Related Concept Videos
Antifungal Agents
Anthelminthic Agents
Antiprotozoal Agents
Fungal Phylum Microsporidia
Candidiasis
Cryptococcal Meningitis
